Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.10.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities:    
Net loss $ (27,379) $ (27,442)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 828 119
Amortization of debt discounts and issuance costs   3,740
Costs of warrants issued 207 5,790
Write-off of debt discounts and debt issuance costs at IPO   10,132
Change in fair value of warrant liability 15 (7,114)
Provision for doubtful accounts 22 67
Stock-based compensation expense 5,125 1,903
Changes in assets and liabilities:    
Accounts receivable (3,914) (7,476)
Expenditures billable to clients (900) (4,918)
Prepaid expenses and other current assets (367) (1,303)
Accounts payable 2,421 6,042
Accrued media payments 1,945 2,206
Client advances 1,148 1,248
Other accrued liabilities (966) 529
Other liabilities 474  
Net cash used in operating activities (21,341) (16,477)
Cash flows from investing activities:    
Proceeds from sales of marketable securities 14,000  
Capital expenditures (2,899)  
Intangible assets acquired (70) (30)
Net cash provided by (used in) investing activities 11,031 (30)
Cash flows from financing activities:    
Proceeds from common stock offerings, net 32,536 33,199
Proceeds from exercise of Primary Warrant   29,263
Proceeds received under the Bridge Loan Agreement   8,000
Proceeds from issuances of stock under employee stock plans 921 3
Debt issuance costs   (68)
Other   (56)
Net cash provided by financing activities 33,457 70,341
Net increase in cash and cash equivalents 23,147 53,834
Cash and cash equivalents, beginning of period 29,545 12,078
Cash and cash equivalents, end of period 52,692 65,912
Non-cash investing and financing activities:    
Conversion of convertible notes payable, including accrued interest, to common stock   28,782
Conversion of redeemable convertible preferred stock to common stock   27,266
Unpaid deferred public offering costs $ 384 $ 665